We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Breast Tomosynthesis Can Rule Out Cancer Without Additional Scan

By HospiMedica International staff writers
Posted on 22 Mar 2011
The first commercially available breast cancer screening and diagnosis system provides the potential of breast tomosynthesis, a cutting-edge technology poised to transform how breast cancer is currently detected.

Hologic, Inc. More...
(Bedford, MA, USA), a developer, manufacturer, and supplier of diagnostics products, medical imaging systems and surgical products focused on serving the healthcare needs of women, showcased the Selenia Dimensions three-dimensional (3D) mammography and other new, ready-to-market technologies in women's imaging at the 21st annual US National Interdisciplinary Breast Center Conference (NCBC) in Las Vegas, NV, USA, March 12-16, 2011. The NCBC is a nonprofit membership organization dedicated to excellence in breast healthcare for the public.

Mammography systems using traditional 2D imaging have limitations caused by tissue overlapping, tissue in the breast that may hide lesions, or cause benign areas to appear suspicious. In clinical studies, radiologists reading 2D plus 3D mammography (breast tomosynthesis) compared to 2D mammography alone demonstrated superior clinical performance in specificity, the confidence to rule out breast cancer without recalling the patient for additional study, and also demonstrated improved sensitivity, the proportion of mammograms that include breast cancers that were correctly diagnosed.

Hologic's Selenia Dimensions systems are installed in more than a dozen countries and cleared for sale in 40 countries. Selenia Dimensions 3D was approved for sale in the United States by the US Food and Drug Administration (FDA) on February 11, 2011.

Selenia Dimensions provides the exceptional 2D images the industry has come to expect from Hologic and, for the first time ever, gives radiologists the option of offering their patients a conventional 2D digital mammogram and a 3D tomosynthesis exam all under one compression, in just seconds, at a combined X-ray dose below the FDA's acceptable maximum guidelines for screening mammography.

Also shown for the first time at NCBC are two new products designed specifically for our Selenia Dimensions 2D/3D system: the Affirm upright breast biopsy-guidance system and ImageChecker 3D Calc computer-aided detection (CAD). Affirm is cleared for sale in the United States. ImageChecker 3D Calc is a work in progress and is not available for sale in the United States.

Related Links:

Hologic




Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Medical Monitor
SILENIO D
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.